NCT06124508 PromotinG Lung Cancer screenIng Awareness and Implementation in Hispanics/Latinx Head and Neck canceR Survivors
| NCT ID | NCT06124508 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Miami |
| Condition | Head and Neck Cancer |
| Study Type | INTERVENTIONAL |
| Enrollment | 44 participants |
| Start Date | 2024-04-11 |
| Primary Completion | 2029-04-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 44 participants in total. It began in 2024-04-11 with a primary completion date of 2029-04-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to assess the awareness of eligibility of lung cancer screening in Hispanic/LatinX Head and Neck Cancer (HNC) survivors using a survey questionnaire; and to understand the barriers to screening using qualitative interviews.
Eligibility Criteria
Inclusion Criteria: * Participants must be able to understand, and sign informed consent form. * Age ≥ 18 years. * Participants must self-identify as Hispanic/LatinX. * Individuals must be head and neck cancer survivors (treated locally with surgery, radiation alone, or definitive chemoradiation ≥ 5 years earlier and have no signs/symptoms to suggest recurrence of disease). * Subjects that meet lung cancer (LC) screening eligibility according to United States Preventive Services Task Force (USPSTF21) and/or National Comprehensive Cancer Network (NCCN). For patients with a history of head and neck cancers, the NCCN recommends annual screening with low dose computerized tomography (LDCT) in those who have had a history of 20 pack years of smoking or more. USPSTF21 LC screening eligibility includes adults ages 50-80 that are current smoker or former smokers that quit within 15 years and have a 20 pack-year history or more of smoking. Exclusion Criteria: * Individuals with pre-established diagnosis of lung cancer. * Participants with current diagnosis of any active malignancy. * Subjects that had undergone lung imaging within previous 3 years. * Pregnant or nursing mothers. * Individuals that received head and neck related treatment less than 5 years before screening. * Individuals with \< 20 pack year history of smoking. * Subjects with previous history of distant metastatic head and neck cancer.
Contact & Investigator
Coral Olazagasti, MD
PRINCIPAL INVESTIGATOR
University of Miami
Frequently Asked Questions
Who can join the NCT06124508 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 80 Years, studying Head and Neck Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06124508 currently recruiting?
Yes, NCT06124508 is actively recruiting participants. Contact the research team at cxo379@med.miami.edu for enrollment information.
Where is the NCT06124508 trial being conducted?
This trial is being conducted at Miami, United States.
Who is sponsoring the NCT06124508 clinical trial?
NCT06124508 is sponsored by University of Miami. The principal investigator is Coral Olazagasti, MD at University of Miami. The trial plans to enroll 44 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.